Aurora Therapeutics, cofounded by Nobel Prize–winning scientist Jennifer Doudna, plans to use gene editing and a new FDA ...
Scientists have used CRISPR to give the goldenberry a modern makeover, shrinking the plant by about a third and making it ...
The need to change regulations around gene-editing treatments was endorsed in November by the head of the US Food and Drug ...
A new CRISPR breakthrough shows scientists can turn genes back on without cutting DNA, by removing chemical tags that act ...
A patient death in a CRISPR trial halts gene editing studies, raising critical safety questions. What this means for the ...
Innovative research into the gene-editing tool targets influenza’s ability to replicate—stopping it in its tracks.
A new CRISPR approach can control genes without cutting DNA, opening a safer path for treating genetic diseases. A newly ...
Across all domains of life, immune defenses foil invading viruses by making it impossible for the viruses to replicate. Most ...
The gene therapy success with Baby KJ, along with a new FDA program, have companies more interested in treating rare disease.
If you are wondering whether CRISPR Therapeutics at about US$53.84 is still priced attractively or already baking in a lot of ...
Victoria Gray spent 34 years battling the debilitating pain of sickle cell disease. Then she volunteered to be the world's first "prototype" for a CRISPR therapy, based on technology invented at UC ...
Zacks Investment Research on MSN
CRISPR Therapeutics AG (CRSP) stock slides as market rises: Facts to know before you trade
CRISPR Therapeutics AG (CRSP) ended the recent trading session at $53.84, demonstrating a -4.54% change from the preceding ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results